nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—esophageal cancer	0.436	0.731	CbGaD
Spironolactone—ABCB1—esophageal cancer	0.16	0.269	CbGaD
Spironolactone—ABCC2—Carboplatin—esophageal cancer	0.0752	0.283	CbGbCtD
Spironolactone—ABCC2—Cisplatin—esophageal cancer	0.0643	0.242	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—esophageal cancer	0.0503	0.189	CbGbCtD
Spironolactone—ABCC2—Methotrexate—esophageal cancer	0.0417	0.157	CbGbCtD
Spironolactone—ABCB1—Cisplatin—esophageal cancer	0.0209	0.0787	CbGbCtD
Spironolactone—ABCB1—Methotrexate—esophageal cancer	0.0136	0.0511	CbGbCtD
Spironolactone—SHBG—neck—esophageal cancer	0.0013	0.0737	CbGeAlD
Spironolactone—Hydrocortisone—ANXA1—esophageal cancer	0.000943	0.232	CrCbGaD
Spironolactone—Testolactone—CYP19A1—esophageal cancer	0.000899	0.222	CrCbGaD
Spironolactone—NR3C2—bronchus—esophageal cancer	0.000846	0.0479	CbGeAlD
Spironolactone—CYP11B2—lymph node—esophageal cancer	0.000846	0.0479	CbGeAlD
Spironolactone—NR3C2—smooth muscle tissue—esophageal cancer	0.000828	0.0469	CbGeAlD
Spironolactone—PGR—epithelium—esophageal cancer	0.000799	0.0452	CbGeAlD
Spironolactone—PGR—smooth muscle tissue—esophageal cancer	0.000769	0.0436	CbGeAlD
Spironolactone—NR3C2—trachea—esophageal cancer	0.00076	0.043	CbGeAlD
Spironolactone—NR3C1—neck—esophageal cancer	0.000677	0.0383	CbGeAlD
Spironolactone—NR3C2—digestive system—esophageal cancer	0.000654	0.037	CbGeAlD
Spironolactone—AR—epithelium—esophageal cancer	0.000636	0.036	CbGeAlD
Spironolactone—AR—bronchus—esophageal cancer	0.000627	0.0355	CbGeAlD
Spironolactone—AR—smooth muscle tissue—esophageal cancer	0.000613	0.0347	CbGeAlD
Spironolactone—SLCO1A2—digestive system—esophageal cancer	0.00056	0.0317	CbGeAlD
Spironolactone—NR3C2—lung—esophageal cancer	0.000546	0.0309	CbGeAlD
Spironolactone—ABCC2—digestive system—esophageal cancer	0.000522	0.0295	CbGeAlD
Spironolactone—PGR—lung—esophageal cancer	0.000507	0.0287	CbGeAlD
Spironolactone—AR—digestive system—esophageal cancer	0.000484	0.0274	CbGeAlD
Spironolactone—SLCO1A2—lung—esophageal cancer	0.000468	0.0265	CbGeAlD
Spironolactone—NR3C1—epithelium—esophageal cancer	0.000461	0.0261	CbGeAlD
Spironolactone—NR3C1—bronchus—esophageal cancer	0.000454	0.0257	CbGeAlD
Spironolactone—NR3C1—smooth muscle tissue—esophageal cancer	0.000444	0.0251	CbGeAlD
Spironolactone—NR3C1—trachea—esophageal cancer	0.000407	0.0231	CbGeAlD
Spironolactone—AR—lung—esophageal cancer	0.000404	0.0229	CbGeAlD
Spironolactone—NR3C2—lymph node—esophageal cancer	0.000373	0.0211	CbGeAlD
Spironolactone—Methyltestosterone—CYP19A1—esophageal cancer	0.000366	0.0901	CrCbGaD
Spironolactone—NR3C1—digestive system—esophageal cancer	0.000351	0.0198	CbGeAlD
Spironolactone—PGR—lymph node—esophageal cancer	0.000347	0.0196	CbGeAlD
Spironolactone—Progesterone—CYP1B1—esophageal cancer	0.000306	0.0754	CrCbGaD
Spironolactone—ABCC2—lymph node—esophageal cancer	0.000298	0.0169	CbGeAlD
Spironolactone—NR3C1—lung—esophageal cancer	0.000293	0.0166	CbGeAlD
Spironolactone—Testosterone—CYP1B1—esophageal cancer	0.000289	0.0712	CrCbGaD
Spironolactone—AR—lymph node—esophageal cancer	0.000276	0.0157	CbGeAlD
Spironolactone—Drospirenone—PTGS2—esophageal cancer	0.000268	0.066	CrCbGaD
Spironolactone—Megestrol acetate—ABCB1—esophageal cancer	0.000261	0.0643	CrCbGaD
Spironolactone—ABCB1—epithelium—esophageal cancer	0.000247	0.014	CbGeAlD
Spironolactone—Progesterone—CYP2A6—esophageal cancer	0.000236	0.0581	CrCbGaD
Spironolactone—ABCB1—trachea—esophageal cancer	0.000218	0.0123	CbGeAlD
Spironolactone—Testosterone—CYP19A1—esophageal cancer	0.000212	0.0523	CrCbGaD
Spironolactone—NR3C1—lymph node—esophageal cancer	0.0002	0.0113	CbGeAlD
Spironolactone—ABCB1—digestive system—esophageal cancer	0.000188	0.0106	CbGeAlD
Spironolactone—Ulcer—Cisplatin—esophageal cancer	0.000173	0.0353	CcSEcCtD
Spironolactone—Hyperkalaemia—Cisplatin—esophageal cancer	0.000161	0.0328	CcSEcCtD
Spironolactone—Rash erythematous—Capecitabine—esophageal cancer	0.000158	0.0321	CcSEcCtD
Spironolactone—Body temperature increased—Carboplatin—esophageal cancer	0.000157	0.0321	CcSEcCtD
Spironolactone—ABCB1—lung—esophageal cancer	0.000157	0.00887	CbGeAlD
Spironolactone—Renal failure acute—Cisplatin—esophageal cancer	0.000129	0.0262	CcSEcCtD
Spironolactone—Ulcer—Capecitabine—esophageal cancer	0.000128	0.026	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—esophageal cancer	0.000108	0.0265	CrCbGaD
Spironolactone—ABCB1—lymph node—esophageal cancer	0.000107	0.00607	CbGeAlD
Spironolactone—Cramp muscle—Cisplatin—esophageal cancer	0.000107	0.0218	CcSEcCtD
Spironolactone—Ulcer—Methotrexate—esophageal cancer	9.49e-05	0.0194	CcSEcCtD
Spironolactone—Renal failure acute—Capecitabine—esophageal cancer	9.48e-05	0.0193	CcSEcCtD
Spironolactone—Vasculitis—Methotrexate—esophageal cancer	9.2e-05	0.0188	CcSEcCtD
Spironolactone—Renal failure—Cisplatin—esophageal cancer	9e-05	0.0183	CcSEcCtD
Spironolactone—Lethargy—Capecitabine—esophageal cancer	8.94e-05	0.0182	CcSEcCtD
Spironolactone—Progesterone—ABCB1—esophageal cancer	8.77e-05	0.0216	CrCbGaD
Spironolactone—Testosterone—ABCB1—esophageal cancer	8.29e-05	0.0204	CrCbGaD
Spironolactone—Ataxia—Capecitabine—esophageal cancer	8.23e-05	0.0168	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—esophageal cancer	8.03e-05	0.0164	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	7.89e-05	0.0161	CcSEcCtD
Spironolactone—Gastritis—Capecitabine—esophageal cancer	7.75e-05	0.0158	CcSEcCtD
Spironolactone—Alopecia—Cisplatin—esophageal cancer	7.26e-05	0.0148	CcSEcCtD
Spironolactone—Renal failure acute—Methotrexate—esophageal cancer	7.06e-05	0.0144	CcSEcCtD
Spironolactone—Muscle spasms—Cisplatin—esophageal cancer	6.88e-05	0.014	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	6.69e-05	0.0136	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—esophageal cancer	6.65e-05	0.0136	CcSEcCtD
Spironolactone—Ill-defined disorder—Cisplatin—esophageal cancer	6.64e-05	0.0135	CcSEcCtD
Spironolactone—Renal failure—Capecitabine—esophageal cancer	6.63e-05	0.0135	CcSEcCtD
Spironolactone—Malaise—Cisplatin—esophageal cancer	6.45e-05	0.0132	CcSEcCtD
Spironolactone—Leukopenia—Cisplatin—esophageal cancer	6.4e-05	0.0131	CcSEcCtD
Spironolactone—Agranulocytosis—Capecitabine—esophageal cancer	6.3e-05	0.0128	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—esophageal cancer	6.13e-05	0.0125	CcSEcCtD
Spironolactone—Discomfort—Cisplatin—esophageal cancer	6.02e-05	0.0123	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	5.87e-05	0.012	CcSEcCtD
Spironolactone—Anaphylactic shock—Cisplatin—esophageal cancer	5.84e-05	0.0119	CcSEcCtD
Spironolactone—Erythema multiforme—Capecitabine—esophageal cancer	5.73e-05	0.0117	CcSEcCtD
Spironolactone—Thrombocytopenia—Cisplatin—esophageal cancer	5.72e-05	0.0117	CcSEcCtD
Spironolactone—Eosinophilia—Methotrexate—esophageal cancer	5.58e-05	0.0114	CcSEcCtD
Spironolactone—Alopecia—Capecitabine—esophageal cancer	5.35e-05	0.0109	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—esophageal cancer	5.19e-05	0.0106	CcSEcCtD
Spironolactone—Muscle spasms—Capecitabine—esophageal cancer	5.07e-05	0.0103	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cisplatin—esophageal cancer	5.04e-05	0.0103	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—esophageal cancer	5.02e-05	0.0102	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	4.98e-05	0.0102	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—esophageal cancer	4.94e-05	0.0101	CcSEcCtD
Spironolactone—Ill-defined disorder—Capecitabine—esophageal cancer	4.89e-05	0.00998	CcSEcCtD
Spironolactone—Feeling abnormal—Cisplatin—esophageal cancer	4.81e-05	0.00981	CcSEcCtD
Spironolactone—Malaise—Capecitabine—esophageal cancer	4.76e-05	0.0097	CcSEcCtD
Spironolactone—Leukopenia—Capecitabine—esophageal cancer	4.72e-05	0.00962	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—esophageal cancer	4.69e-05	0.00956	CcSEcCtD
Spironolactone—Body temperature increased—Cisplatin—esophageal cancer	4.62e-05	0.00941	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—PSME1—esophageal cancer	4.57e-05	0.000412	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ADH7—esophageal cancer	4.56e-05	0.000411	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLCE1—esophageal cancer	4.56e-05	0.000411	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PFN1—esophageal cancer	4.53e-05	0.000409	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.52e-05	0.000407	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.5e-05	0.000406	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALDH2—esophageal cancer	4.49e-05	0.000405	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	4.45e-05	0.000401	CbGpPWpGaD
Spironolactone—Discomfort—Capecitabine—esophageal cancer	4.44e-05	0.00904	CcSEcCtD
Spironolactone—PGR—Gene Expression—PSME2—esophageal cancer	4.38e-05	0.000395	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PSME1—esophageal cancer	4.38e-05	0.000395	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	4.36e-05	0.000394	CbGpPWpGaD
Spironolactone—Confusional state—Capecitabine—esophageal cancer	4.34e-05	0.00885	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—CREBBP—esophageal cancer	4.32e-05	0.00039	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	4.31e-05	0.000388	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HIST1H2BM—esophageal cancer	4.3e-05	0.000388	CbGpPWpGaD
Spironolactone—Hypersensitivity—Cisplatin—esophageal cancer	4.3e-05	0.00877	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—GSTT1—esophageal cancer	4.27e-05	0.000385	CbGpPWpGaD
Spironolactone—Erythema multiforme—Methotrexate—esophageal cancer	4.26e-05	0.00869	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—CYP2A6—esophageal cancer	4.22e-05	0.000381	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Capecitabine—esophageal cancer	4.21e-05	0.00859	CcSEcCtD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	4.21e-05	0.00038	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.2e-05	0.000379	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	4.17e-05	0.000376	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	4.16e-05	0.000375	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH3—esophageal cancer	4.13e-05	0.000373	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ELMO1—esophageal cancer	4.07e-05	0.000367	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	4.04e-05	0.000365	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	4.03e-05	0.000363	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS1—esophageal cancer	4e-05	0.000361	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO1—esophageal cancer	4e-05	0.000361	CbGpPWpGaD
Spironolactone—Diarrhoea—Cisplatin—esophageal cancer	3.99e-05	0.00814	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.99e-05	0.00036	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ADH1B—esophageal cancer	3.99e-05	0.00036	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	3.99e-05	0.00036	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	3.99e-05	0.00036	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	3.99e-05	0.00036	CbGpPWpGaD
Spironolactone—Alopecia—Methotrexate—esophageal cancer	3.98e-05	0.00812	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—AKAP13—esophageal cancer	3.98e-05	0.000359	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1B1—esophageal cancer	3.95e-05	0.000356	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PSME2—esophageal cancer	3.94e-05	0.000355	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PSME1—esophageal cancer	3.94e-05	0.000355	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.93e-05	0.000355	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.91e-05	0.000352	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	3.9e-05	0.000352	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.85e-05	0.000347	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	3.82e-05	0.000345	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMP—esophageal cancer	3.82e-05	0.000344	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NR1I2—esophageal cancer	3.81e-05	0.000343	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH1—esophageal cancer	3.77e-05	0.00034	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.75e-05	0.000338	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	3.74e-05	0.000337	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Capecitabine—esophageal cancer	3.72e-05	0.00758	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—CYP26A1—esophageal cancer	3.71e-05	0.000335	CbGpPWpGaD
Spironolactone—Vomiting—Cisplatin—esophageal cancer	3.71e-05	0.00757	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—CYP19A1—esophageal cancer	3.71e-05	0.000335	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH2—esophageal cancer	3.71e-05	0.000334	CbGpPWpGaD
Spironolactone—Rash—Cisplatin—esophageal cancer	3.68e-05	0.00751	CcSEcCtD
Spironolactone—Dermatitis—Cisplatin—esophageal cancer	3.68e-05	0.0075	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—HIST1H2BM—esophageal cancer	3.67e-05	0.000331	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Methotrexate—esophageal cancer	3.64e-05	0.00743	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—PDE4D—esophageal cancer	3.64e-05	0.000328	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	3.63e-05	0.000328	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALOX15—esophageal cancer	3.62e-05	0.000326	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.56e-05	0.000321	CbGpPWpGaD
Spironolactone—Feeling abnormal—Capecitabine—esophageal cancer	3.55e-05	0.00723	CcSEcCtD
Spironolactone—Malaise—Methotrexate—esophageal cancer	3.54e-05	0.00722	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—esophageal cancer	3.51e-05	0.00716	CcSEcCtD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.48e-05	0.000314	CbGpPWpGaD
Spironolactone—Nausea—Cisplatin—esophageal cancer	3.47e-05	0.00707	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—GNG7—esophageal cancer	3.46e-05	0.000312	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TPI1—esophageal cancer	3.45e-05	0.000311	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTO1—esophageal cancer	3.45e-05	0.000311	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.44e-05	0.00031	CbGpPWpGaD
Spironolactone—Urticaria—Capecitabine—esophageal cancer	3.42e-05	0.00697	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—CREBBP—esophageal cancer	3.42e-05	0.000308	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.41e-05	0.000308	CbGpPWpGaD
Spironolactone—Body temperature increased—Capecitabine—esophageal cancer	3.4e-05	0.00694	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—CYP1B1—esophageal cancer	3.4e-05	0.000307	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—HMOX1—esophageal cancer	3.39e-05	0.000305	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.34e-05	0.000301	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PSME2—esophageal cancer	3.34e-05	0.000301	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PSME1—esophageal cancer	3.34e-05	0.000301	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.32e-05	0.0003	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALDOB—esophageal cancer	3.31e-05	0.000298	CbGpPWpGaD
Spironolactone—Discomfort—Methotrexate—esophageal cancer	3.3e-05	0.00673	CcSEcCtD
Spironolactone—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	3.29e-05	0.000297	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	3.26e-05	0.000294	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCB1—esophageal cancer	3.25e-05	0.000293	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—XIAP—esophageal cancer	3.24e-05	0.000293	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.23e-05	0.000291	CbGpPWpGaD
Spironolactone—Confusional state—Methotrexate—esophageal cancer	3.23e-05	0.00659	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—esophageal cancer	3.2e-05	0.00653	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—CYP19A1—esophageal cancer	3.2e-05	0.000288	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GAPDH—esophageal cancer	3.19e-05	0.000287	CbGpPWpGaD
Spironolactone—Hypersensitivity—Capecitabine—esophageal cancer	3.17e-05	0.00646	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—CRABP1—esophageal cancer	3.16e-05	0.000285	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH3—esophageal cancer	3.15e-05	0.000284	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Methotrexate—esophageal cancer	3.14e-05	0.0064	CcSEcCtD
Spironolactone—PGR—Gene Expression—SMAD4—esophageal cancer	3.11e-05	0.000281	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC52A3—esophageal cancer	3.1e-05	0.000279	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BLVRB—esophageal cancer	3.1e-05	0.000279	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNA1—esophageal cancer	3.07e-05	0.000277	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL2—esophageal cancer	3.05e-05	0.000275	CbGpPWpGaD
Spironolactone—Pruritus—Capecitabine—esophageal cancer	3.04e-05	0.00621	CcSEcCtD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.03e-05	0.000273	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNG7—esophageal cancer	3e-05	0.000271	CbGpPWpGaD
Spironolactone—Diarrhoea—Capecitabine—esophageal cancer	2.94e-05	0.006	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—HMOX1—esophageal cancer	2.92e-05	0.000263	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.86e-05	0.000258	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSME2—esophageal cancer	2.85e-05	0.000257	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSME1—esophageal cancer	2.85e-05	0.000257	CbGpPWpGaD
Spironolactone—Somnolence—Methotrexate—esophageal cancer	2.85e-05	0.00581	CcSEcCtD
Spironolactone—Dizziness—Capecitabine—esophageal cancer	2.85e-05	0.0058	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—ANXA1—esophageal cancer	2.84e-05	0.000256	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH2—esophageal cancer	2.83e-05	0.000255	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALDH2—esophageal cancer	2.81e-05	0.000254	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCB1—esophageal cancer	2.8e-05	0.000253	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.77e-05	0.00025	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Methotrexate—esophageal cancer	2.77e-05	0.00564	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—SST—esophageal cancer	2.76e-05	0.000249	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	2.76e-05	0.000248	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.74e-05	0.000248	CbGpPWpGaD
Spironolactone—Vomiting—Capecitabine—esophageal cancer	2.74e-05	0.00558	CcSEcCtD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.71e-05	0.000245	CbGpPWpGaD
Spironolactone—Rash—Capecitabine—esophageal cancer	2.71e-05	0.00553	CcSEcCtD
Spironolactone—Dermatitis—Capecitabine—esophageal cancer	2.71e-05	0.00553	CcSEcCtD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.7e-05	0.000244	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BLVRB—esophageal cancer	2.7e-05	0.000243	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.7e-05	0.000243	CbGpPWpGaD
Spironolactone—Headache—Capecitabine—esophageal cancer	2.7e-05	0.0055	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—NOTCH3—esophageal cancer	2.69e-05	0.000242	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GHRL—esophageal cancer	2.69e-05	0.000242	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTT1—esophageal cancer	2.68e-05	0.000241	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	2.65e-05	0.000239	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FBXW7—esophageal cancer	2.64e-05	0.000238	CbGpPWpGaD
Spironolactone—Feeling abnormal—Methotrexate—esophageal cancer	2.64e-05	0.00538	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.64e-05	0.000238	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA1—esophageal cancer	2.63e-05	0.000237	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC10A2—esophageal cancer	2.63e-05	0.000237	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—esophageal cancer	2.57e-05	0.000231	CbGpPWpGaD
Spironolactone—Nausea—Capecitabine—esophageal cancer	2.56e-05	0.00521	CcSEcCtD
Spironolactone—Urticaria—Methotrexate—esophageal cancer	2.55e-05	0.00519	CcSEcCtD
Spironolactone—NR3C1—Gene Expression—PSME2—esophageal cancer	2.53e-05	0.000228	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PSME1—esophageal cancer	2.53e-05	0.000228	CbGpPWpGaD
Spironolactone—Body temperature increased—Methotrexate—esophageal cancer	2.53e-05	0.00516	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—PTGS1—esophageal cancer	2.51e-05	0.000226	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO1—esophageal cancer	2.51e-05	0.000226	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.51e-05	0.000226	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	2.5e-05	0.000225	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PSME2—esophageal cancer	2.47e-05	0.000223	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PSME1—esophageal cancer	2.47e-05	0.000223	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.46e-05	0.000222	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH2—esophageal cancer	2.41e-05	0.000217	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA2—esophageal cancer	2.41e-05	0.000217	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	2.39e-05	0.000215	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SMAD4—esophageal cancer	2.37e-05	0.000214	CbGpPWpGaD
Spironolactone—Hypersensitivity—Methotrexate—esophageal cancer	2.36e-05	0.00481	CcSEcCtD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.35e-05	0.000212	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.33e-05	0.00021	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH1—esophageal cancer	2.3e-05	0.000207	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA1—esophageal cancer	2.29e-05	0.000207	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.29e-05	0.000207	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.28e-05	0.000206	CbGpPWpGaD
Spironolactone—Pruritus—Methotrexate—esophageal cancer	2.27e-05	0.00462	CcSEcCtD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.26e-05	0.000204	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADH7—esophageal cancer	2.24e-05	0.000202	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.24e-05	0.000202	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.21e-05	0.0002	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.21e-05	0.0002	CbGpPWpGaD
Spironolactone—Diarrhoea—Methotrexate—esophageal cancer	2.19e-05	0.00447	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—CREBBP—esophageal cancer	2.17e-05	0.000196	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.16e-05	0.000195	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	2.14e-05	0.000193	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFBR2—esophageal cancer	2.14e-05	0.000193	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	2.13e-05	0.000192	CbGpPWpGaD
Spironolactone—Dizziness—Methotrexate—esophageal cancer	2.12e-05	0.00432	CcSEcCtD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.12e-05	0.000191	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA2—esophageal cancer	2.1e-05	0.000189	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CREBBP—esophageal cancer	2.08e-05	0.000188	CbGpPWpGaD
Spironolactone—Vomiting—Methotrexate—esophageal cancer	2.04e-05	0.00415	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—MYC—esophageal cancer	2.03e-05	0.000183	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMAD4—esophageal cancer	2.02e-05	0.000183	CbGpPWpGaD
Spironolactone—Rash—Methotrexate—esophageal cancer	2.02e-05	0.00412	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—esophageal cancer	2.02e-05	0.00411	CcSEcCtD
Spironolactone—Headache—Methotrexate—esophageal cancer	2.01e-05	0.00409	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	2.01e-05	0.000181	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2e-05	0.00018	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.96e-05	0.000177	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—esophageal cancer	1.95e-05	0.000176	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLCE1—esophageal cancer	1.95e-05	0.000176	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADH7—esophageal cancer	1.95e-05	0.000176	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NOS3—esophageal cancer	1.94e-05	0.000175	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.93e-05	0.000174	CbGpPWpGaD
Spironolactone—Nausea—Methotrexate—esophageal cancer	1.9e-05	0.00388	CcSEcCtD
Spironolactone—CYP2C8—Metabolism—TYMP—esophageal cancer	1.88e-05	0.000169	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CREBBP—esophageal cancer	1.87e-05	0.000169	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.84e-05	0.000166	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMOX1—esophageal cancer	1.83e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.82e-05	0.000165	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SMAD4—esophageal cancer	1.8e-05	0.000162	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.8e-05	0.000162	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—esophageal cancer	1.78e-05	0.00016	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.78e-05	0.00016	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.76e-05	0.000158	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—esophageal cancer	1.75e-05	0.000158	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADH1B—esophageal cancer	1.71e-05	0.000154	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TPI1—esophageal cancer	1.7e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.7e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—esophageal cancer	1.68e-05	0.000151	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.67e-05	0.000151	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—esophageal cancer	1.66e-05	0.000149	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMP—esophageal cancer	1.63e-05	0.000147	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.63e-05	0.000147	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.6e-05	0.000145	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.59e-05	0.000143	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CREBBP—esophageal cancer	1.59e-05	0.000143	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—esophageal cancer	1.58e-05	0.000143	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.57e-05	0.000141	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.57e-05	0.000141	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.55e-05	0.00014	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALOX15—esophageal cancer	1.55e-05	0.00014	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—esophageal cancer	1.53e-05	0.000138	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—esophageal cancer	1.49e-05	0.000135	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	1.48e-05	0.000134	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—esophageal cancer	1.48e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TPI1—esophageal cancer	1.48e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTO1—esophageal cancer	1.48e-05	0.000133	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNG7—esophageal cancer	1.48e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDOB—esophageal cancer	1.42e-05	0.000128	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.38e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GAPDH—esophageal cancer	1.36e-05	0.000123	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.36e-05	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREBBP—esophageal cancer	1.35e-05	0.000122	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CRABP1—esophageal cancer	1.35e-05	0.000122	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.33e-05	0.00012	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	1.33e-05	0.00012	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.32e-05	0.000119	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.32e-05	0.000119	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.3e-05	0.000117	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.3e-05	0.000117	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNG7—esophageal cancer	1.29e-05	0.000116	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—esophageal cancer	1.27e-05	0.000115	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—esophageal cancer	1.24e-05	0.000111	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO1—esophageal cancer	1.23e-05	0.000111	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.23e-05	0.000111	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PSME2—esophageal cancer	1.21e-05	0.00011	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PSME1—esophageal cancer	1.21e-05	0.00011	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—esophageal cancer	1.21e-05	0.000109	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDH2—esophageal cancer	1.2e-05	0.000109	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CREBBP—esophageal cancer	1.2e-05	0.000108	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.17e-05	0.000106	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—esophageal cancer	1.15e-05	0.000103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—esophageal cancer	1.13e-05	0.000102	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.13e-05	0.000102	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—esophageal cancer	1.09e-05	9.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO1—esophageal cancer	1.07e-05	9.68e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS1—esophageal cancer	1.07e-05	9.68e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.07e-05	9.67e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.06e-05	9.56e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PSME1—esophageal cancer	1.06e-05	9.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PSME2—esophageal cancer	1.06e-05	9.54e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.05e-05	9.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.05e-05	9.45e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—esophageal cancer	1e-05	9.03e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	9.85e-06	8.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—esophageal cancer	9.69e-06	8.73e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—esophageal cancer	9.61e-06	8.67e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—esophageal cancer	9.43e-06	8.5e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—esophageal cancer	9.41e-06	8.49e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—esophageal cancer	9.22e-06	8.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.13e-06	8.23e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—esophageal cancer	8.99e-06	8.11e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.82e-06	7.95e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.63e-06	7.78e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.58e-06	7.74e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—esophageal cancer	8.03e-06	7.24e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—esophageal cancer	7.99e-06	7.21e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—esophageal cancer	7.85e-06	7.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—esophageal cancer	7.83e-06	7.06e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—esophageal cancer	7.14e-06	6.44e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—esophageal cancer	6.82e-06	6.15e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—esophageal cancer	6.59e-06	5.95e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.53e-06	5.88e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	5.91e-06	5.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.77e-06	5.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—esophageal cancer	5.16e-06	4.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CREBBP—esophageal cancer	5.03e-06	4.53e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.72e-06	4.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—esophageal cancer	4.5e-06	4.06e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—esophageal cancer	4.11e-06	3.71e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—esophageal cancer	3.93e-06	3.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—esophageal cancer	3.42e-06	3.09e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.91e-06	2.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.53e-06	2.28e-05	CbGpPWpGaD
